Cancer patients could benefit from the combining of Chinese and Western medicine
10/01/2013
Combining traditional forms of Chinese and Western medicine could offer new hope for developing new treatments for liver, lung, colorectal cancers and osteosarcoma of the bones. Experts from Cardiff University's School of Medicine have joined forces with Peking University in China to test the health benefits of a traditional Chinese medicine...
Focus on genomic signature of a tumor may lead to personalized therapy
10/01/2013
Clinical trial design for new cancer therapies has historically been focused on the tissue of origin of a tumor, but a paper from researchers at Memorial Sloan-Kettering Cancer Center published in Nature Genetics supports a new approach: one based on the genomic signature of a tumor rather than the tissue of origin in the body...
For many years, patients with advanced thyroid cancer faced bleak prospects and no viable treatment options. But now, building on recent discoveries about the genetics and cell signaling pathways of thyroid tumors, researchers are developing exciting new weapons against the disease, using kinase inhibitors that target tumor cell division and blood vessels...
The risk of developing and dying from breast and colon cancer increased by diabetes
10/01/2013
Diabetes is linked to an increased risk of developing cancer, and now researchers have performed a unique meta-analysis that excludes all other causes of death and found that diabetic patients not only have an increased risk of developing breast and colon cancer but an even higher risk of dying from them...
The importance of telomere length in prostate cancer prognosis
10/01/2013
Like the plastic caps at the end of shoelaces, telomeres protect - in their case - the interior-gene containing parts of chromosomes that carry a cell's instructional material...
Progression of squamous cell carcinomas reduced in mice
10/01/2013
The c-Fos oncogene has traditionally been linked to cellular activities related to cancer, such as cell division, differentiation - conversion from one cell type to another - or survival. Any alteration of these activities can set off the development of tumours, which has made c-Fos an important target for the understanding and treatment of cancer...
Deadly form of lung cancer may be treatable with FDA-approved antidepressant
10/01/2013
A little-used class of antidepressants appears potentially effective in combating a particularly deadly form of lung cancer, according to a new study from researchers at the Stanford University School of Medicine. And because the drugs have already been approved by the U.S...
'Irrefutable' evidence that colorectal cancer screening has led to fall in death rates
10/01/2013
Screening for colorectal cancer (CRC) in European countries is highly effective in reducing mortality from the disease...
Scientists erase brain tumor cells in mice
10/01/2013
Scientists have discovered that a repurposed drug approved by the US Food and Drug Administration (FDA) is capable of erasing brain tumor cells in mice. This is according to a study published in the journal Oncotarget...
Survival in head and neck cancer patients improved using hyperfractionated radiotherapy
10/01/2013
The use of an intensified form of radiotherapy in patients with locally advanced head and neck cancers can improve overall survival rates compared with standard radiation therapy, according to results from a large study to be presented at the 2013 European Cancer Congress (ECC2013) [1]...